Manos Perros, Entasis CEO
AstraZeneca's former antibiotics unit claims a PhIII win in drug-resistant bacteria affecting sickly patients
The management team at Entasis, AstraZeneca’s old antibiotics unit spun out six years ago, has a new dataset it’s simply delighted to share.
Entasis revealed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.